RxSight to Present at the J.P. Morgan Healthcare Conference

Rhea-AI Summary

RxSight, Inc. (NASDAQ: RXST), a leader in ophthalmic medical devices, will participate in the virtual J.P. Morgan Healthcare Conference on January 13, 2022, at 6:45 am PT / 9:45 am ET. This presentation will focus on their innovative Light Adjustable Lens system, which customizes visual acuity post-cataract surgery. Additionally, the lens now includes ActivShield technology for UV protection. Interested parties can access the live stream via the company’s website.

News Market Reaction – RXST

+1.94%

+1.94% Session move

In the trading session that priced this news, RXST gained 1.94%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALISO VIEJO, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual J.P. Morgan Healthcare Conference.

RxSight® management is scheduled to present Thursday, January 13, 2022, at 6:45am PT / 9:45am ET. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.rxsight.com/.

About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.

Investor Relations Contact:
Philip Taylor
Gilmartin Group
415.937.5406
IR@rxsight.com

FAQ

When will RxSight present at the J.P. Morgan Healthcare Conference?

RxSight will present on January 13, 2022, at 6:45 am PT / 9:45 am ET.

What is the primary product featured by RxSight at the conference?

The primary product is the Light Adjustable Lens system, enhancing vision after cataract surgery.

How can investors access the RxSight conference presentation?

Investors can access the live and archived webcast on the 'Investors' section of RxSight's website.

What new technology does the Light Adjustable Lens feature?

The Light Adjustable Lens now includes ActivShield technology for UV protection.

What is the stock symbol for RxSight?

The stock symbol for RxSight is RXST.